About Us
Pharmaxi MRM Inc. assembles a team of distinguished professionals with extensive expertise in clinical trials and advanced business strategies. This integration allows us to accelerate the delivery of vital therapies to patients for our clients. We guide clients worldwide through the changing landscape of clinical development, helping them meet their business goals in accordance with FDA and EMA standards.
What this means for sponsors:
- -1-Clear governance and accountability
- -2-Senior oversight and operational execution depth
- -3-Regional access and partner ecosystems
- -4-Our managers are always ready to answer your questions. You can call us during the weekends and at night.
Pharmaxi MRM Inc. was established to expand high-quality clinical research services in the U.S. and global biotech markets. With over ten years of experience, Pharmaxi MRM Inc. is a well-established clinical research organization equipped with a robust operational infrastructure and a strong investigator network.
This joint venture model combines proven clinical execution with innovative strategies, enabling Pharmaxi MRM Inc. to deliver high-quality, flexible, and cost-effective CRO services to emerging biotech sponsors. By combining operational strength with strategic guidance, Pharmaxi MRM Inc. accelerates the development of new therapies from early clinical stages to subsequent phases.
This joint venture model combines proven clinical execution with innovative strategies, enabling Pharmaxi MRM Inc. to deliver high-quality, flexible, and cost-effective CRO services to emerging biotech sponsors. By combining operational strength with strategic guidance, Pharmaxi MRM Inc. accelerates the development of new therapies from early clinical stages to subsequent phases.
Our Story
Pharmaxi MRM Inc. is guided by a multidisciplinary team of experts with specialization in clinical research, regulatory affairs, and biotechnology. This team has extensive experience in global drug development and clinical trial management, with a particular emphasis on studies compliant with FDA, TGA, and EMA regulations. To date, the team has successfully conducted over 80 clinical trials across 23 countries, activating more than 930 clinical sites and enrolling in excess of 40,000 patients, while collectively amassing over 250 years of experience. Our leadership team effectively combines operational expertise, strategic vision, and investment acumen, thereby establishing a robust foundation to support innovative sponsors in the biotechnology sector.
The organization assembles clinical project managers, medical experts, regulatory specialists, biostatisticians, data managers, and quality professionals who work collaboratively to deliver high-quality clinical research services. With international experience across various therapeutic areas and regulatory environments, the Pharmaxi MRM Inc. team ensures efficient study execution, scientific rigor, and strict compliance with global regulatory standards.
The organization assembles clinical project managers, medical experts, regulatory specialists, biostatisticians, data managers, and quality professionals who work collaboratively to deliver high-quality clinical research services. With international experience across various therapeutic areas and regulatory environments, the Pharmaxi MRM Inc. team ensures efficient study execution, scientific rigor, and strict compliance with global regulatory standards.
Leadership & Team
Dr. Elena Loukinova, MD, PhD
Director / CEO
Director / CEO
Dr. Elena Loukinova is Director of PharmaxiMRM Inc., leading strategy and operations for clinical research programs. With over 25 years of experience in academia and the life sciences industry, she brings deep expertise in biomedical research, translational science, and clinical development.
She has led complex research initiatives and collaborated across academic institutions, biotech companies, and CROs, combining strong scientific training with hands-on experience in study design, regulatory strategy, and program management.
Dr. Loukinova has extensive experience supporting studies in line with international standards, including ICH-GCP and U.S. regulatory expectations. She works closely with sponsors and investigators to ensure scientific rigor, compliance, and data integrity. Under her leadership, the CRO delivers efficient, high-quality research solutions while building long-term partnerships and advancing innovative therapies.
She has led complex research initiatives and collaborated across academic institutions, biotech companies, and CROs, combining strong scientific training with hands-on experience in study design, regulatory strategy, and program management.
Dr. Loukinova has extensive experience supporting studies in line with international standards, including ICH-GCP and U.S. regulatory expectations. She works closely with sponsors and investigators to ensure scientific rigor, compliance, and data integrity. Under her leadership, the CRO delivers efficient, high-quality research solutions while building long-term partnerships and advancing innovative therapies.
Pascal Brabant, RN, ACD
Project Management
Project Management
Pascal Brabant brings more than 35 years of experience in clinical research and clinical operations. With medical training and prior service in the Canadian Armed Forces, he began his clinical career at the Montreal Heart Institute, where he spent 10 years involved in cardiovascular medicine and clinical research. He later held senior management roles in global CROs including Covance and Keyrus Life Science, and served as a therapeutic lead at Wyeth Pharmaceuticals Canada, overseeing programs in cardiovascular, internal medicine, and infectious diseases. He subsequently held the position of Director of Clinical Operations at Methylene. Over the past 15 years, Mr. Brabant has worked as a clinical operations consultant, supporting sponsors and research organisations across North America and globally. He currently collaborates with Pharmaxi MRM, providing strategic guidance in global clinical operations with a particular focus on North American activities.
Hélène Dubreuil, RN
Lead CRA
Lead CRA
Hélène Dubreuil is a registered nurse with more than 30 years of experience in healthcare and clinical research. She began her career with 10 years of clinical nursing experience within the Quebec Health Network before transitioning to clinical research. She spent six years as a clinical research associate with major organisations including Quintiles and Pfizer, gaining extensive experience in site monitoring and clinical trial oversight. Over the past 20 years, Ms. Dubreuil has worked as an independent consultant specialising in site monitoring, monitoring team leadership, and quality assurance site auditing. She currently supports Pharmaxi MRM by providing expertise in site monitoring, management of monitoring teams, and site auditing to ensure high standards of clinical trial conduct and regulatory compliance.
Pharmaxi MRM Inc.operates through a strategically positioned international footprint spanning the United States, Europe, and the Middle East & North Africa (MENA) region. The company’s U.S. presence supports engagement with global biotech sponsors and regulatory alignment with the U.S. FDA, while Pharmaxi’s established operational infrastructure in Ukraine provides access to experienced clinical research teams, leading investigators, and well-developed clinical trial sites across Eastern Europe.
Through its connection with MRM BioEnt in UAE, Pharmaxi MRM Inc.extends its reach into the rapidly growing MENA biotechnology and healthcare markets. This cross-regional structure enables efficient trial execution, competitive cost structures, and access to diverse patient populations for global clinical development programs.
Through its connection with MRM BioEnt in UAE, Pharmaxi MRM Inc.extends its reach into the rapidly growing MENA biotechnology and healthcare markets. This cross-regional structure enables efficient trial execution, competitive cost structures, and access to diverse patient populations for global clinical development programs.
Global Footprint
